Gf Fund Management Co. Ltd. Avidity Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,505 shares of RNA stock, worth $80,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,505Holding current value
$80,285% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$354 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$302 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$276 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$254 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$240 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.67B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...